An Article in the Sydney Morning Herald during the week has highlighted the increasing trend of companies seeking finance based on anticipated R&D Tax Entitlements.
This allows companies to access funding now, based on a portion of what their anticipated R&D Refund is expected to be, once claims can be lodged after 30 June.
Providers of such finance usually require:
There are fees and charges associated with these finance products, and companies pursuing this should ensure that:
Swanson Reed has established working relationships with providers of such finance mentioned in the article, namely Radium Capital, and found their terms and processes to be reasonable and efficient.
Swanson Reed is a separate business from the financiers, and receives no commissions from our clients who engage them.
A link to Radium Capital’s website is here.